American Society of Transplantation and Cellular Therapy Series: #7 - Management of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients.
Transplant Cell Ther
; 29(12): 730-738, 2023 Dec.
Article
en En
| MEDLINE
| ID: mdl-37783338
ABSTRACT
The Practice Guidelines Committee of the American Society of Transplantation and Cellular Therapy (ASTCT) partnered with its Transplant Infectious Disease Special Interest Group (TID-SIG) to update the 2009 compendium-style infectious disease guidelines for hematopoietic cell transplantation (HCT). A new approach was adopted to better serve clinical providers by publishing each standalone topic in the infectious disease series in a concise format of frequently asked questions (FAQ), tables, and figures. Experts in HCT and infectious diseases identified FAQs and then provided answers based on the strength of the recommendation and the level of supporting evidence. In the seventh guideline in the series, we focus on the respiratory syncytial virus (RSV) with FAQs addressing epidemiology, clinical diagnosis, prophylaxis, and treatment. Special consideration was given to RSV in pediatric, cord blood, haploidentical, and T cell-depleted HCT and chimeric antigen receptor T cell therapy recipients, as well as to identify future research directions.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Asunto principal:
Enfermedades Transmisibles
/
Virus Sincitial Respiratorio Humano
/
Infecciones por Virus Sincitial Respiratorio
/
Trasplante de Células Madre Hematopoyéticas
Tipo de estudio:
Guideline
Límite:
Child
/
Humans
País/Región como asunto:
America do norte
Idioma:
En
Revista:
Transplant Cell Ther
Año:
2023
Tipo del documento:
Article